133 related articles for article (PubMed ID: 6208738)
1. Antithrombin III Trento. A 'new' congenital AT III abnormality with a peculiar crossed-immunoelectrophoretic pattern in the absence of heparin.
Girolami A; Marafioti F; Rubertelli M; Vicarioto MA; Cappellato G; Mazzuccato M
Acta Haematol; 1984; 72(2):73-82. PubMed ID: 6208738
[TBL] [Abstract][Full Text] [Related]
2. An abnormal plasma antithrombin with no apparent affinity for heparin.
Chasse JF; Esnard F; Guitton JD; Mouray H; Perigois F; Fauconneau G; Gauthier F
Thromb Res; 1984 May; 34(4):297-302. PubMed ID: 6204398
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
Okajima K; Abe H; Wagatsuma M; Okabe H; Takatsuki K
Am J Hematol; 1995 Jan; 48(1):12-8. PubMed ID: 7832187
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease.
Girolami A; Pengo V; Cappellato G; Vianello C; Procidano M; Cartei C
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):98-111. PubMed ID: 6192061
[TBL] [Abstract][Full Text] [Related]
5. Familial thrombosis due to antithrombin III deficiency in a Greek family.
Stathakis NE; Papayannis AG; Antonopoulos M; Gardikas C
Acta Haematol; 1977; 57(1):47-54. PubMed ID: 65891
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.
Girolami A; Fabris F; Cappellato G; Sainati L; Boeri G
Blut; 1983 Aug; 47(2):93-103. PubMed ID: 6871478
[TBL] [Abstract][Full Text] [Related]
7. Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis.
Sakuragawa N; Takahashi K; Kondo S; Koide T
Thromb Res; 1983 Jul; 31(2):305-17. PubMed ID: 6636045
[TBL] [Abstract][Full Text] [Related]
8. Immunoelectrophoretic evidence of a thrombin-induced abnormality in a new variant of hereditary dysfunctional antithrombin III (AT III 'Vicenza').
Barbui T; Finazzi G; Rodeghiero F; Dini E
Br J Haematol; 1983 Aug; 54(4):561-5. PubMed ID: 6871107
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis.
Lane DA; Lowe GD; Flynn A; Thompson E; Ireland H; Erdjument H
Br J Haematol; 1987 Aug; 66(4):523-7. PubMed ID: 3663509
[TBL] [Abstract][Full Text] [Related]
10. Behaviour of antithrombin III abnormalities in the crossed immunoelectrophoresis system.
Girolami A; Cappellato G; Vicarioto MA; Vergolani A; Traverso R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):159-64. PubMed ID: 2581861
[TBL] [Abstract][Full Text] [Related]
11. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
de Moerloose PA; Reber G; Vernet P; Minazio P; Bouvier CA
Thromb Haemost; 1987 Apr; 57(2):154-7. PubMed ID: 3603409
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin III Pescara: a defective AT III variant with no alterations of plasma crossed immunoelectrophoresis, but with an abnormal crossed immunoelectrofocusing pattern.
Leone G; De Stefano V; Di Donfrancesco A; Ferrelli R; Traisci G; Bizzi B
Br J Haematol; 1987 Feb; 65(2):187-91. PubMed ID: 3828226
[TBL] [Abstract][Full Text] [Related]
13. A functional abnormal antithrombin III (AT III) deficiency: AT III Charleville.
Aiach M; Nora M; Fiessinger JN; Roncato M; François D; Gelas MA
Thromb Res; 1985 Sep; 39(5):559-70. PubMed ID: 4082101
[TBL] [Abstract][Full Text] [Related]
14. Crossed immunoelectrophoresis as applied to studies on complex formation. The binding of heparin to antithrombin III and the antithrombin III--thrombin complex.
Andersson LO; Engman L; Henningsson E
J Immunol Methods; 1977; 14(3-4):271-81. PubMed ID: 557071
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin III Alger: a new homozygous AT III variant.
Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M
Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called ATIII-Barcelona 2.
Fontcuberta J; Grau E; Rubio N; Félez J; Rutllant ML
Thromb Res; 1988 Jul; 51(1):75-81. PubMed ID: 3413737
[TBL] [Abstract][Full Text] [Related]
17. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
[TBL] [Abstract][Full Text] [Related]
18. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest.
Sas G; Pepper DS; Cash JD
Thromb Diath Haemorrh; 1975 Jun; 33(3):564-72. PubMed ID: 1154312
[TBL] [Abstract][Full Text] [Related]
19. Homozygous variant of antithrombin III: AT III Fontainebleau.
Boyer C; Wolf M; Vedrenne J; Meyer D; Larrieu MJ
Thromb Haemost; 1986 Aug; 56(1):18-22. PubMed ID: 3775688
[TBL] [Abstract][Full Text] [Related]
20. Immunoelectrophoretic quantitation of antithrombin III. Electroimmunodiffusion in agarose gels containing heparin.
Grimmer O; Fagerhol MK
Int J Pept Protein Res; 1977; 9(2):85-90. PubMed ID: 402327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
